CVD Risk and Prevention in Early Glucose Intolerance.
Phase of Trial: Phase II
Latest Information Update: 14 Aug 2017
At a glance
- Drugs Aspirin; Olmesartan medoxomil; Thioctic acid
- Indications Cardiovascular disorders
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 28 Jun 2012 Actual patient number changed from 4 to 84 as reported by ClinicalTrials.gov.
- 21 Jun 2011 Actual end date (May 2011) and actual patient number (88) added, as reported by ClinicalTrials.gov record.